Editorial board member Nicola A Hanania (Baylor College of Medicine, TX, US) considers the role of biologics in the management of asthma and chronic obstructive pulmonary disease (COPD).
1. What have been the most promising advances in molecular phenotyping of asthma and chronic obstructive pulmonary disease (COPD)? (0:12)
2. How are selective blood biomarkers being used to inform therapeutic decisions in COPD and asthma patients? (1:33)
3. What are the advantages and limitations of the new biologic therapies in severe asthma and COPD? (2:50)
4. What is the role of macrolides in the treatment paradigm of severe asthma and COPD? (5:14)
5. What do you see as the remaining unmet needs in this area? (6:47)
Speaker disclosure: Nicola A Hanania has received honoraria for serving on advisory boards or as a consultant for Boehringer Ingelheim, GlaxoSmithKline, AstraZeneca, Novartis, and Sanofi/Regeneron. His institution has received research grant support on his behalf from Boehringer Ingelheim, AstraZeneca, Roche, and GlaxoSmithKline.
Filmed at the European Respiratory Society (ERS) International Congress 2018, Paris, France, September 2018.
Share this Video
Related Videos In COPD
Brian Carlin, CHEST 2020 – New Thoughts in COPD
Brian Carlin (Pittsburgh Critical Care Associates, Pittsburgh, PA, US) talks to us about recent developments in the treatment of COPD and the impact COVID-19 has had on pulmonary rehabilitation services. Questions 1. What have been the most exciting recent developments in inhaled therapies for COPD? (0:20) 2. What factors should physicians consider before prescribing inhaled […]
Peter J Barnes, ERS 2020 – Smart Inhalers for COPD and Asthma
During the ERS International Congress 2020, it was great to catch up with our Editorial Board member, Prof. Peter J Barnes (Imperial College, London, UK), to continue the discussion around Smart Inhalers and how they could help optimise inhaler use in patients. Questions How common is poor adherence and inhaler technique in people with asthma […]
Henrik Hansen, ERS 2019 – Pulmonary Tele-rehabilitation Versus Conventional Rehabilitation (Part 1)
We met Henrik Hansen, from National University Hospital, Copenhagen, Denmark, at ERS 2019 to discuss his study results – 1-year follow-up of pulmonary tele-rehabilitation versus conventional pulmonary rehabilitation. Questions 1. What are the limitations of current pulmonary rehabilitation programmes? (0:05) 2. What are the potential advantages and limitations of tele-rehabilitation? (1:44) Speaker disclosures: Henrik Hansen […]
Journal articles and more to your inbox
Get the latest clinical insights from touchRESPIRATORYSign me up!